Web Agent - Monitor small-cap companies listed on the Nasdaq or NYSE within emerging technological sectors that have experienced a significant surge in stock price over the past 3-6 months. Identify and collect recent news, press releases, analyst reports, and any other publicly available web data that could explain the rapid price appreciation. Focus on companies with market capitalizations below $2 billion.
Bionano Genomics (NASDAQ: BNGO) shares have appreciated 110% over the past three months, following the August 12, 2026, announcement of a peer--reviewed study in a leading medical journal demonstrating the superior diagnostic yield of its "Saphyr" optical genome mapping (OGM) system compared to traditional cytogenetics for blood cancers. The data showed that OGM identified clinically relevant structural variants missed by standard methods in 25% of cases. Analysts attribute the surge to the company's successful efforts in securing Category I CPT codes, which facilitates widespread insurance reimbursement and clinical adoption.